TWEAK is a positive regulator of cardiomyocyte proliferation

Cardiovascular Research

Volumn 85, Issue 4, 2010, Pages 681-690

  Novoyatleva, Tatyana ^a   Diehl, Florian ^a   Van Amerongen, MacHteld J ^a   Patra, Chinmoy ^a   Ferrazzi, Fulvia ^b   Bellazzi, Riccardo ^b   Engel, Felix B ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cardiomyocytes; FN14; Heart; Proliferation; Signalling; TWEAK

Indexed keywords

AURORA B KINASE; CYCLIN D2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYTOKINE; DNA; GLYCOGEN SYNTHASE KINASE 3BETA; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 12A; TUMOR NECROSIS FACTOR RELATED WEAK INDUCER OF APOPTOSIS; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CELL CYCLE; CELL PROLIFERATION; CELL STIMULATION; CELL TYPE; CONTROLLED STUDY; CYTOKINESIS; DNA SYNTHESIS; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; HEART MUSCLE CELL; MITOSIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS REGULATORY PROTEINS; CELL DIVISION; CELLS, CULTURED; CYCLIN D2; FEMALE; GENE EXPRESSION; KI-67 ANTIGEN; MEMBRANE PROTEINS; MITOSIS; MYOCYTES, CARDIAC; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; REGENERATION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTORS;

EID: 76749098833     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp360     Document Type: Article

References (41)

1. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T et al. Heart Disease and Stroke Statistics-2006 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-e151.
2. Engel FB, Schebesta M, Duong MT, Lu G, Ren S, Madwed JB et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 2005;15:1175-1187.
3. Bersell K, Arab S, Haring B, Kuhn B. Neuregulin1/ErbB4 signaling induces cardio-myocyte proliferation and repair of heart injury. Cell 2009;138:257-270.
4. Kuhn B, Del Monte F, Hajjar RJ, Chang YS, Lebeche D, Arab S et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med 2007;13:962-969.
5. Engel FB, Hsieh PC, Lee RT, Keating MT. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myo-cardial infarction. Proc Natl Acad Sci USA 2006;103:15546-15551.
6. Jakubowski A, Ambrose C, Parr M, Lincecum JM, Wang MZ, Zheng TS et al. TWEAK induces liver progenitor cell proliferation. J Clin Invest 2005;115: 2330-2340.
7. Girgenrath M, Weng S, Kostek CA, Browning B, Wang M, Brown SA et al. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J 2006;25:5826-5839.
8. Sugito T, Mineshiba F, Zheng C, Cotrim AP, Goldsmith CM, Baum BJ. Transient TWEAK overexpression leads to a general salivary epithelial cell proliferation. Oral Dis 2009;15:76-81.
9. Gao HX, Campbell SR, Burkly LC, Jakubowski A, Jarchum I, Banas B et al. TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells. Cytokine 2009;46:24-35.
10. Sanz AB, Sanchez-Nino MD, Izquierdo MC, Jakubowski A, Justo P, Blanco-Colio LM et al. Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy-induced renal hyperplasia. J Cell Mol Med 2009; [Epub ahead of print].
11. Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 1997;272:32401-32410.
12. Harada N, Nakayama M, Nakano H, Fukuchi Y, Yagita H, Okumura K. Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. Biochem Biophys Res Commun 2002;299:488-493.
13. Nakayama M, Harada N, Okumura K, Yagita H. Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies. Biochem Biophys Res Commun 2003;306:819-825.
14. Ando T, Ichikawa J, Wako M, Hatsushika K, Watanabe Y, Sakuma M et al. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells. Arthritis Res Ther 2006;8:R146.
15. Brown SA, Richards CM, Hanscom HN, Feng SL, Winkles JA. The Fn14 cyto-plasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation. Biochem J 2003;371:395-403.
16. Saitoh T, Nakayama M, Nakano H, Yagita H, Yamamoto N, Yamaoka S. TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. J Biol Chem 2003;278:36005-36012.
17. Dogra C, Changotra H, Wedhas N, Qin X, Wergedal JE, Kumar A. TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J 2007;21:1857-1869.
18. Engel FB, Hauck L, Boehm M, Nabel EG, Dietz R, von Harsdorf R. p21(CIP1) Controls proliferating cell nuclear antigen level in adult cardiomyocytes. Mol Cell Biol 2003;23:555-565.
19. Engel FB, Hauck L, Cardoso MC, Leonhardt H, Dietz R, von Harsdorf R. A mammalian myocardial cell-free system to study cell cycle reentry in terminally differentiated cardiomyocytes. Circ Res 1999;85:294-301.
20. Tran NL, McDonough WS, Savitch BA, Sawyer TF, Winkles JA, Berens ME. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression. J Biol Chem 2005;280:3483-3492.
21. Ebelt H, Hufnagel N, Neuhaus P, Neuhaus H, Gajawada P, Simm A et al. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardio-myocytes without activation of apoptosis. Circ Res 2005;96:509-517.
22. Gresch O, Engel FB, Nesic D, Tran TT, England HM, Hickman ES et al. New non-viral method for gene transfer into primary cells. Methods 2004;33:151-163.
23. Busk PK, Hinrichsen R, Bartkova J, Hansen AH, Christoffersen TE, Bartek J et al. Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy. Exp Cell Res 2005;304:149-161.
24. Pasumarthi KBS, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ. Targeted expression of Cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res 2005;96:110-118.
25. Brown DC, Gatter KC. Ki67 protein: the immaculate deception? Histopathology 2002;40:2-11.
26. Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell 2008;14:159-169.
27. Ajiro K, Yoda K, Utsumi K, Nishikawa Y. Alteration of cell cycle-dependent histone phosphorylations by okadaic acid. Induction of mitosis-specific H3 phos-phorylation and chromatin condensation in mammalian interphase cells. J Biol Chem 1996;271:13197-13201.
28. Brodsky VY. Cell Ploidy in the Mammalian Heart. New York: Harwood Academic Publishers; 1991.
29. Engel FB, Schebesta M, Keating MT. Anillin localization defect in cardiomyocyte binucleation. J Mol Cell Cardiol 2006;41:601-612.
30. Tseng AS, Engel FB, Keating MT. The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes. Chem Biol 2006;13:957-963.
31. Hassink RJ, Pasumarthi KB, Nakajima H, Rubart M, Soonpaa MH, de la Riviere AB et al. Cardiomyocyte cell cycle activation improves cardiac function after myocar-dial infarction. Cardiovasc Res 2008;78:18-25.
32. Yepes M. TWEAK and the central nervous system. Mol Neurobiol 2007;35: 255-265.
33. Potrovita I, Zhang W, Burkly L, Hahm K, Lincecum J, Wang MZ et al. Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration. J Neurosci 2004;24:8237-8244.
34. Burkly LC, Michaelson JS, Hahm K, Jakubowski A, Zheng TS. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease. Cytokine 2007;40:1-16.
35. Jain M, Jakubowski A, Cui L, Shi J, Su L, Bauer M et al. A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure. Circulation 2009;119:2058-2068.
36. Chorianopoulos E, Heger T, Lutz M, Frank D, Bea F, Katus HA et al. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardi-omyocytes and mediates nuclear factor-kappaB activation by TWEAK. Basic Res Cardiol 2009; [Epub ahead of print].
37. Kerkela R, Kockeritz L, Macaulay K, Zhou J, Doble BW, Beahm C et al. Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardio-myoblast hyperproliferation. J Clin Invest 2008;118:3609-3618.
38. Jin Y, Pasumarthi KB, Bock ME, Lytras A, Kardami E, Cattini PA. Cloning and expression of fibroblast growth factor receptor-1 isoforms in the mouse heart: evidence for isoform switching during heart development. J Mol Cell Cardiol 1994;26:1449-1459.
39. Ieda M, Tsuchihashi T, Ivey KN, Ross RS, Hong TT, Shaw RM et al. Cardiac fibro-blasts regulate myocardial proliferation through beta1 integrin signaling. Dev Cell 2009;16:233-244.
40. Zhao YY, Sawyer DR, Baliga RR, Opel DJ, Han X, Marchionni MA et al. Neuregu-lins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem 1998; 273:10261-10269.
41. Zhao YY, Feron O, Dessy C, Han X, Marchionni MA, Kelly RA. Neuregulin signaling in the heart. Dynamic targeting of erbB4 to caveolar microdomains in cardiac myocytes. Circ Res 1999;84:1380-1387.